在COVID-19大流行中对抗凝血剂的管理达成了德尔菲共识:MONACO研究
Carlos Escobar1, Ramón Bover Freire2, Xavier García-Moll Marimón3
1Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.
Cardiovascular diagnosis and therapy
|November 9, 2023
概括
这份专家共识为COVID-19患者的口服抗凝药管理提供了建议. 它涉及诸如心房动,血栓预防和大流行期间远程医疗使用等关键领域.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 快速发布的COVID-19抗凝指南缺乏结构化的方法,并显示了显著的差异.
- 现有的指导方针没有提供统一的方法来管理大流行期间的口服抗凝药.
研究的目的:
- 在COVID-19大流行期间为患者的口服抗凝剂的临床管理制定专家共识建议.
- 为了解决对抗凝血管理结构化指导的需求,在冲突的试验数据中.
主要方法:
- 一个两轮的德尔菲研究利用在线调查.
- 专家小组成员在9点的利克特级别上对协议进行了评分,共识是通过≥66.6%的批准和科学委员会同意来定义的.
主要成果:
- 在五个关键层面的161个项目上达成共识.
- 维度涵盖了心房的抗凝剂,COVID-19血栓预防,离院后的管理,监测和远程医疗.
结论:
- 该共识为临床医生管理COVID-19患者的抗凝药提供了关键的指导.
- 在临床试验数据有限或相互矛盾的情况下,建议对于住院和出院决定特别有价值.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Endocarditis III: Medical Management
8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8


